<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03400657</url>
  </required_header>
  <id_info>
    <org_study_id>CSMDT-01</org_study_id>
    <nct_id>NCT03400657</nct_id>
  </id_info>
  <brief_title>MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer</brief_title>
  <official_title>A Prospective, Multicenter, Prospective, Non-intervention, Controlled Trial of MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer in Realistic Medical Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multicenter, non-interventional, controlled clinical study. Evaluate
      MDT performance and benefit analysis in patients with advanced gastric or colorectal cancer
      after MDT discussion under real medical practice.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>overall survival</measure>
    <time_frame>From date of enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months</time_frame>
    <description>From date of enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in overall survival after performing MDT at center</measure>
    <time_frame>1 years</time_frame>
    <description>Differences in overall survival after performing MDT at center</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">484</enrollment>
  <condition>Multi-disciplinary Treatment</condition>
  <arm_group>
    <arm_group_label>fully implemented to the MDT decision</arm_group_label>
    <description>group of patients fully implemented to the MDT decision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>not completly implemented to the MDT-decision</arm_group_label>
    <description>group of patients not completly implemented to the MDT decision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>not implemented to the MDT decision</arm_group_label>
    <description>group of patients not implemented to the MDT decision</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Multi-disciplinary Treatment</intervention_name>
    <description>due to suggestion of Multi-disciplinary Treatment ,the patients would be suggested to chemotherapy or surgery.</description>
    <arm_group_label>fully implemented to the MDT decision</arm_group_label>
    <arm_group_label>not completly implemented to the MDT-decision</arm_group_label>
    <arm_group_label>not implemented to the MDT decision</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        recurrent / metastatic gastric or colorectal cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Histopathological diagnosis of recurrent / metastatic gastric or colorectal cancer.

          2. Participate in formal MDT discussions at the Research Center.

          3. MDT decision-making at least two subjects involved in treatment.

          4. Patient informed consent and signed written consent.

        Exclusion Criteria:

          1. Early or locally advanced gastric cancer or colorectal cancer.

          2. Accept informal MDT discussions.

          3. MDT decisions recommend only a single subject for treatment of patients.

          4. MDT decisions recommend only palliative patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Beijing Cancer Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100142</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2018</study_first_submitted>
  <study_first_submitted_qc>January 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2018</study_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University</investigator_affiliation>
    <investigator_full_name>Shen Lin</investigator_full_name>
    <investigator_title>Head of department of Gastroentestinal oncology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

